Research poster
 • 
June 2020

Development of a real-world evidence platform in NF2 to examine treatment patterns and outcomes

Neurofibromatosis type 2 (NF2) is a rare disease, and its low prevalence can make it challenging to conduct clinical research on long-term clinical outcomes of patients who use off-label therapies for management. See how AllStripes’ real-world data (RWD) platform can be used to understand disease burden and treatment patterns over time. This poster was presented at Children’s Tumor Foundation’s 2021 Neurofibromatosis Virtual Conference in June 2020.
Research for:

Access your records, drive treatment research

Search for something